Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol. 2010;2:26-9.Schmaltz, R, Vogt, T, Reichrath, J (2010) Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol 2: pp. 26-9...
tions for Treatment Autoinflammation in the TNF Receptor-Associated Periodic Syndrome (TRAPS): Pathophysiology and Implications for TreatmentAutoinflammation in the TNF Receptor-Associated Periodic Syndrome (TRAPS): Pathophysiology and Implications for TreatmentImmunology Autoinflammation in the TNF Receptor-...
Acute coronary syndrome (ACS) is a group of clinical syndromes caused by acute myocardial ischemia, which can cause heart failure, arrhythmia and even sudden death. It is the major cause of disability and death worldwide. Neutrophil extracellular traps (
TNF Receptor–Associated Periodic Syndrome (TRAPS) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - Medical Professional Version.
B. et al. Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media—a potential treatment target. PLOS ONE 8, e53837 (2013). CAS PubMed PubMed Central Google Scholar Delaleu, N. et al. Sjogren’s syndrome patients with ...
SIV, a specific inhibitor of NE, has demonstrated efficacy in the treatment of respiratory diseases, including acute lung injury or acute respiratory distress syndrome with systemic inflammatory response syndrome [20]. Likewise, our results suggested that both SIV and HVO effectively inhibit NETs ...
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an autosomal dominantly inherited autoinflammatory disease caused by mutations in the TNFRSF1A gene. Treatment is aimed at preventing acute disease attacks, improving quality of life, and preventing long-term complications such as syst...
Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefevre syndrome patients. J. Periodontol. 65, 364–371 (1994). CAS PubMed Google Scholar Hart, T. C. & Shapira, L. Papillon-Lefevre syndrome. Periodontol 2000 6, 88–100 (1994). CAS PubMed...
Sivelestat, an NE inhibitor, is mainly used for treating acute lung injury and acute respiratory distress syndrome. By inhibiting neutrophil elastase activity, it blocks the formation of NETs [184,185,186,187,188]. Sivelestat has potential in cancer treatment by inhibiting NETs formation in a mo...
However, it has been observed that pulmonary surfactant administration is not beneficial in adults with acute lung injury or acute respiratory distress syndrome [128]. Despite the potential benefits of pulmonary surfactants in the treatment of respiratory diseases, their clinical applications still face ...